Chairman
Dongchao Technology Group
Shanghai, China
As a promoter of China's high-tech globalization, particularly in introducing commercial satellite technology and the biomedical field to Arab partners, including peptide active pharmaceutical ingredients (such as semaglutide and tirzepatide)
As the founder of Dongchao International Group, I have been deeply engaged in overseas cooperation for over a decade. Together with my team, I have successfully promoted the high-tech international expansion of the group and its partners, including the export of commercial satellites and related technical services to multiple countries in the Middle East region of China, as well as customized pharmaceutical collaborations. Our company focuses on building a "turnkey" service platform for peptide drug factories, targeting the "global blockbuster with tens of billions in sales—the king of glucose-lowering and weight-loss drugs." By integrating the advantages of "equipment, process, and system," we provide end-to-end CDMO solutions for peptide APIs, covering everything from molecular structure to marketing authorization. With full-chain control and accelerated transformation, we make peptide drug development as simple and reliable as playing with LEGO. Currently, we are actively engaging with partners in Latin America, the Middle East, Central Asia, Southeast Asia, and other regions. We believe this will become a new growth driver for technology going global and achieving win-win results worldwide. Hong Kong serves as the overseas headquarters of Dongchao Group. We look forward to joining hands with you to explore the global market together.
1. Project Investment Interests/ Business Interests
Target Cooperation Sector(s)
Public Utilities
Technology
Other Sector(s)
低空技术及定制化服务（尤其是无人机应用及反制）
Target Market(s)
Interested format(s) of cooperation
Looking for Environmental, Social, and Governance (ESG) projects?
NoProject
我司重点打造“全球百亿销量－降糖、减重药王”的多肽类药物工厂“交钥匙”服务平台，集聚“设备－工艺－体系”三维融合优势，提供端到端的多肽原料药CDMO解决方案。